1h Free Analyst Time
The autism spectrum disorder market is forecasted to grow by USD 3.43 billion during 2024-2029, accelerating at a CAGR of 7.6% during the forecast period. The report on the autism spectrum disorder market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of autism, mergers and acquisitions, and government initiatives.
The autism spectrum disorder market is segmented as below:
By Type
- Non-pharmacological therapies
- Pharmacological therapies
By Age Group
- Pediatric
- Adult
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the autism spectrum disorder market covers the following areas:
- Autism Spectrum Disorder Market sizing
- Autism Spectrum Disorder Market forecast
- Autism Spectrum Disorder Market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Analysis
3 Market Landscape
4 Market Sizing
5 Historic Market Size
6 Qualitative Analysis
7 Five Forces Analysis
8 Market Segmentation by Type
9 Market Segmentation by Age Group
10 Customer Landscape
11 Geographic Landscape
12 Drivers, Challenges, and Opportunity/Restraints
13 Competitive Landscape
14 Competitive Analysis
15 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global autism spectrum disorder market: Autism Services Inc., AUTISM SPECTRUM CONSULTANTS INC., Autism Spectrum Therapies, Behavior Frontiers, BlueSprig, Bristol Myers Squibb Co., Cadabams Hospitals, Center for Autism and Related Disorders, CureMark LLC, FFL Partners LLC, Hopebridge LLC, Ihear, Johnson and Johnson Inc., Magnet ABA Therapy, Max Healthcare Institute Ltd, Merck and Co. Inc., Novartis AG, Otsuka Holdings Co. Ltd., Wellness Hub, and Yamo Pharmaceuticals LLC.Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is partnerships and collaborations."
According to the report, one of the major drivers for this market is the increasing prevalence of autism.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Autism Services Inc.
- AUTISM SPECTRUM CONSULTANTS INC.
- Autism Spectrum Therapies
- Behavior Frontiers
- BlueSprig
- Bristol Myers Squibb Co.
- Cadabams Hospitals
- Center for Autism and Related Disorders
- CureMark LLC
- FFL Partners LLC
- Hopebridge LLC
- Ihear
- Johnson and Johnson Inc.
- Magnet ABA Therapy
- Max Healthcare Institute Ltd
- Merck and Co. Inc.
- Novartis AG
- Otsuka Holdings Co. Ltd.
- Wellness Hub
- Yamo Pharmaceuticals LLC
